Keyword: Viekira Pak

News

European Price Wars Seen Shaping up Over Hepatitis C Drugs

20.01.2015 - Europe, where about 15 million people are believed to be infected with hepatitis C, could become the next battleground between US drugmakers Gilead Sciences and AbbVie in their...

News

US Insurer Aetna to Reimburse Gilead Hepatitis Drug

19.01.2015 - The largest US health insurer, Aetna, has negotiated a discount for Gilead Sciences' hepatitis C treatment regime and said it plans to offer this as a preferred choice for its...

News

Express Scripts to Reimburse AbbVie Hepatitis C Drug

23.12.2014 - The largest pharmacy benefit manager in the US, Express Scripts, has negotiated a cheaper price from AbbVie for its Viekira Pak hepatitis C treatment approved by the US Food and...